CompuCom Named Disruptor in Avasant’s RadarView and a Major Contender in Everest Group’s PEAK Matrix
Reports highlight CompuCom’s digital workspaces and capabilities across global markets FORT MILL, S.C.–(BUSINESS WIRE)–With solutions…
Reports highlight CompuCom’s digital workspaces and capabilities across global markets FORT MILL, S.C.–(BUSINESS WIRE)–With solutions…
BOSTON–(BUSINESS WIRE)–NWN Carousel, the leading integrated Cloud Communications Service Provider, today announced it has received…
SANTA CLARA, Calif.–(BUSINESS WIRE)–#AI—CLARA Analytics (“CLARA”), the leading provider of artificial intelligence (AI) technology in…
Expert Insights names Egress Protect the ‘top email encryption solution for Office 365’. London –…
Migrating to a secure, compliant cloud infrastructure through ClearDATA’s managed services, Apricus Health enhanced patient…
Foundation will promote a diverse and inclusive workforce, advance free and open solutions for underserved…
LEXINGTON, Mass., April 05, 2022 (GLOBE NEWSWIRE) — Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company…
ISELIN, N.J., April 05, 2022 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical…
SAN CARLOS, Calif., April 05, 2022 (GLOBE NEWSWIRE) — Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage…
SOUTH SAN FRANCISCO, Calif., April 05, 2022 (GLOBE NEWSWIRE) — Pliant Therapeutics, Inc. (Nasdaq: PLRX),…
LAS VEGAS, April 05, 2022 (GLOBE NEWSWIRE) — CLS Holdings USA, Inc. (OTCQB:CLSH) (CSE:CLSH), the…
– Total Product Revenues Expected in the Range of $450.0 million to $465.0 million –…
XMT-1660 demonstrates robust activity in preclinical models of breast cancer XMT-2056 demonstrates robust activity as…
–Seasoned physician, scientist and life science executive brings expertise in clinical research and development across…
LONDON, April 05, 2022 (GLOBE NEWSWIRE) — Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical…
A Potential Multi-Billion Dollar Global Market Opportunity for Cancer Treatments MONTREAL, April 05, 2022 (GLOBE…
CAMBRIDGE, Mass., April 05, 2022 (GLOBE NEWSWIRE) — Cullinan Oncology, Inc. (Nasdaq: CGEM) (“Cullinan”) a…
BELTSVILLE, Md., April 05, 2022 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical…
CARMEL, Ind., April 05, 2022 (GLOBE NEWSWIRE) — MBX Biosciences, Inc., a clinical stage biopharmaceutical…
Dr. Mellion brings deep experience in neuromuscular disease research and treatment as a biopharma executive,…